World's Best Scientists 2026 revealed!
Erik J. Bergstralh

Erik J. Bergstralh

D-Index & Metrics

Medicine

D-Index
113
Citations
39218
World Ranking
5014
National Ranking
2718

Erik J. Bergstralh publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Erik J. Bergstralh sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 272 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Erik J. Bergstralh D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Erik J. Bergstralh sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 113 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Erik J. Bergstralh was affiliated with the Mayo Clinic in the United States and contributed to the field of medicine with a focus on ophthalmology and related subfields. Their research covered various aspects of eye disorders, emphasizing ophthalmology, glaucoma, retinal disorders, and drug-induced ocular toxicity.

The main fields of study in Bergstralh's work included:

  • Medicine

Within these, subfields addressed were:

  • Ophthalmology
  • Pathology and Forensic Medicine

Bergstralh's work focused on several key topics:

  • Ophthalmology and Eye Disorders
  • Glaucoma and Retinal Disorders
  • Drug-Induced Ocular Toxicity

One notable recent publication by Bergstralh was "A Prospective, Randomized, Double-blind, Placebo-controlled Study of Orbital Radiotherapy for Graves' Ophthalmopathy," published in 2020 in the journal Ophthalmology.

Their research was published in venues such as:

  • Ophthalmology

Bergstralh collaborated with various co-authors across their research projects, including:

  • Colum A. Gorman
  • James A. Garrity
  • Vahab Fatourechi
  • Rebecca S. Bahn
  • Ivy A. Petersen

Erik J. Bergstralh's contributions to ophthalmology and medicine were part of a broader scientific effort to investigate eye-related diseases and therapeutic interventions, as evident in their collaborative clinical research and publication record.

Best Publications

  • Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989

    Ian D. Hay;Erik J. Bergstralh;John R. Goellner;Janet R. Ebersold

  • Using Serum Creatinine To Estimate Glomerular Filtration Rate: Accuracy in Good Health and in Chronic Kidney Disease

    Andrew D. Rule;Timothy S. Larson;Erik J. Bergstralh;Jeff M. Slezak

  • Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer

    Horst Zincke;Joseph E. Oesterling;Michael L. Blute;Erik J. Bergstralh

  • Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984.

    S Katusic;C M Beard;E Bergstralh;L T Kurland

  • Predicting renal outcome in IgA nephropathy.

    M G Radford;J V Donadio;E J Bergstralh;J P Grande

  • Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate‐specific antigen testing: 15‐year outcome

    John F. Ward;Jeffrey M. Slezak;Michael L. Blute;Erik J. Bergstralh

  • Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?

    Christopher L. Amling;Erik J. Bergstralh;Michael L. Blute;Jeffrey M. Slezak

  • Lung Cancer Mortality in the Mayo Lung Project: Impact of Extended Follow-up

    Pamela M. Marcus;Erik J. Bergstralh;Richard M. Fagerstrom;David E. Williams

  • Papillary thyroid microcarcinoma : a study of 535 cases observed in a 50-year period: Discussion

    I. D. Hay;C.S. Grant;J. A. Van Heerden;J. R. Goellner

  • Glomerular filtration rate estimated by cystatin C among different clinical presentations

    A.D. Rule;E.J. Bergstralh;J.M. Slezak;J. Bergert

  • A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group.

    James V. Donadio;Erik J. Bergstralh;Kenneth P. Offord;Dorothy C. Spencer

  • Comparison of self-reported and medical record health care utilization measures.

    Rosebud O. Roberts;Erik J. Bergstralh;Luanne Schmidt;Steven J. Jacobsen

  • Screening for lung cancer. A critique of the Mayo Lung Project.

    Robert S. Fontana;David R. Sanderson;Lewis B. Woolner;William F. Taylor

  • Systemic mast cell disease. Analysis of 58 cases and literature review.

    William D. Travis;Chin-yang Li;Erik J. Bergstralh;Lung T. Yam

  • Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables.

    J. Jeffrey Ruegemer;Ian D. Hay;Erik J. Bergstralh;John J. Ryan

  • LONG-TERM HAZARD OF PROGRESSION AFTER RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER: CONTINUED RISK OF BIOCHEMICAL FAILURE AFTER 5 YEARS

    Christopher L. Amling;Michael L. Blute;Erik J. Bergstralh;Thomas M. Seay

  • Measured and estimated GFR in healthy potential kidney donors.

    Andrew D Rule;Hiie M Gussak;Gregory R Pond;Erik J Bergstralh

  • Incidence rates of stroke in the eighties: the end of the decline in stroke?

    J P Broderick;S J Phillips;J P Whisnant;W M O'Fallon

  • Risk of prostate carcinoma death in patients with lymph node metastasis.

    Liang Cheng;Horst Zincke M.D.;Michael L. Blute;Erik J. Bergstralh

  • Unilateral total lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?

    Ian D. Hay;Clive S. Grant;Erik J. Bergstralh;Geoffrey B. Thompson

Frequent Co-Authors

Horst Zincke
Horst Zincke Mayo Clinic
Michael L. Blute
Michael L. Blute Harvard University
Steven J. Jacobsen
Steven J. Jacobsen Kaiser Permanente
Joseph E. Oesterling
Joseph E. Oesterling University of Michigan–Ann Arbor
David G. Bostwick
David G. Bostwick Bostwick Laboratories
Ian D. Hay
Ian D. Hay Mayo Clinic
Clive S. Grant
Clive S. Grant Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine offers more options than just becoming a physician. With technology rapidly transforming healthcare, many students are pursuing alternative medical careers through online degrees. These flexible programs are ideal for busy professionals, career changers, or those looking for affordable study options.

For example, online pharmacy programs allow graduates to move into medication management and pharmaceutical research from anywhere in the U.S. Similarly, students interested in health data can benefit from rhit programs online, preparing them for roles in health information and records management.

In the fast-growing field of medical administration, options such as medical billing and coding are in high demand. Students should consider the average cost of medical billing and coding program to plan their investment wisely. Nursing, another essential field, offers many online advanced practice pathways. The cheapest online acute care nurse practitioner programs can help registered nurses advance their credentials without leaving their current roles.

These online programs give students diverse ways to start or advance a healthcare career, making medicine more accessible than ever before.

Best Scientists Citing Erik J. Bergstralh

Recently Published Articles